This demo presents SeizNet, an innovative system for predicting epileptic seizures benefiting from a multi-modal sensor network and utilizing Deep Learning (DL) techniques. Epilepsy affects approximately 65 million people worldwide, many of whom experience drug-resistant seizures. SeizNet aims at providing highly accurate alerts, allowing individuals to take preventive measures without being disturbed by false alarms. SeizNet uses a combination of data collected through either invasive (intracranial electroencephalogram (iEEG)) or non-invasive (electroencephalogram (EEG) and electrocardiogram (ECG)) sensors, and processed by advanced DL algorithms that are optimized for real-time inference at the edge, ensuring privacy and minimizing data transmission. SeizNet achieves > 97% accuracy in seizure prediction while keeping the size and energy restrictions of an implantable device.

In this paper, we introduce SeizNet, a closed-loop system for predicting epileptic seizures through the use of Deep Learning (DL) method and implantable sensor networks. While pharmacological treatment is effective for some epilepsy patients (with ~65M people affected worldwide), one out of three suffer from drug-resistant epilepsy. To alleviate the impact of seizure, predictive systems have been developed that can notify such patients of an impending seizure, allowing them to take precautionary measures. SeizNet leverages DL techniques and combines data from multiple recordings, specifically intracranial electroencephalogram (iEEG) and electrocardiogram (ECG) sensors, that can significantly improve the specificity of seizure prediction while preserving very high levels of sensitivity. SeizNet DL algorithms are designed for efficient real-time execution at the edge, minimizing data privacy concerns, data transmission overhead, and power inefficiencies associated with cloud-based solutions. Our results indicate that SeizNet outperforms traditional single-modality and non-personalized prediction systems in all metrics, achieving up to 99% accuracy in predicting seizure, offering a promising new avenue in refractory epilepsy treatment.